secwatch.observer — SEC 8-K summary
======================================

Issuer:     APPLIED GENETIC TECHNOLOGIES CORP (—)
CIK:        0001273636
Form:       8-K
Filed at:   2022-12-01T23:59:59+00:00
Accession:  0001193125-22-295981
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AGTC acquisition by Alliance Holdco completed; $0.34 cash plus CVR per share
----------------------------------------------------------------------------

- 36,359,379 shares (~53% of outstanding) validly tendered; merger closed under DGCL 251(h) without vote.
- Aggregate cash consideration ~$23.5M; each share gets $0.34 cash plus one CVR worth up to ~$0.73.
- All prior directors removed; new directors: Chris Hollowood, David Fellows, Ashwin Datt; Fellows President, Hollowood Treasurer/Secretary, Datt Assistant Secretary.
- Company requested Nasdaq delisting and intends to file Form 15 to terminate SEC reporting.
- Loan agreement with Hercules Capital terminated and all obligations repaid.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1273636/000119312522295981/0001193125-22-295981-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1273636/000119312522295981/d384471d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-295981

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer